ArticleThe Journal of clinical endocrinology and metabolism2020

Denosumab for Fibrous Dysplasia: Promising, but Questions Remain.

Michael T Collins et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.